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Abstract 
 This thesis will explore the research on interventions used to manage neonatal abstinence 
syndrome (NAS). NAS is a drug withdrawal syndrome that affects a baby after birth who was 
exposed to drugs, typically opiates, in utero. Symptoms include extreme irritability and 
inconsolability caused by hyperactivity of the central nervous system and gastrointestinal system. 
The literature examined explores the employment of non-pharmacological interventions such as 
breastfeeding, swaddling, kangaroo care, rooming- in, and the eat-sleep-console method, as first 
priority interventions. As these interventions are becoming more and more prevalent in practice, 
it is necessary to understand which interventions are efficient at reducing length of treatment of 
pharmacologic management and length and cost of stay. In addition, it is necessary to evaluate 
the same outcomes with regards to pharmacologic interventions in order to identify the best 
practice in the case that medications become ethically necessary. Beyond the review of current 
literature, this paper will identify best-practice recommendations, a proposed implementation 
plan, and a proposed evaluation of the implementation process.   
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CHAPTER 1 
Introduction 
Statement of Purpose 
 The purpose of this thesis is to develop best practice recommendations to better provide 
care for babies with neonatal abstinence syndrome (NAS) in neonatal intensive care units 
(NICU). In this thesis, recommendations for best practice will be created using evidence-based 
research that discusses various treatment methods for NAS and their effects on neonatal 
outcomes. The background of the issue along with the relevance of the topic to nursing practice 
will be provided, followed by an evaluation of the evidence-based research as it pertains to NAS 
treatments. Lastly, a proposed best practice recommendation will be outlined with the objective 
of improving outcomes of babies that suffer from NAS after birth.  
Background of Issue  
Neonatal abstinence syndrome is a drug withdrawal syndrome that affects a baby after 
birth who was exposed to drugs, typically opiates, in utero. Prescription medications, including 
oxycodone, dilaudid, methadone, buprenorphine, fentanyl, and illicit drugs, like heroin, can 
cause NAS. NAS includes a range of physiologic and neurobehavioral signs and symptoms such 
as, hyper-irritability, tremors, hyperreflexia, high-pitched crying, difficulty being consoled, poor 
feeding, diarrhea, vomiting, weight loss, sleep problems, apnea, yawning, sneezing, sweating, 
runny nose, and watery eyes (Durham & Chapman, 2014, p. 469). Short and long-term effects of 
NAS include prematurity, hypoxia, intrauterine growth restriction, low birth weight, 
microcephaly, increased risk for meconium fluid aspiration, congenital infections, increased risk 
for sudden infant death syndrome, and an increased risk for chromosomal abnormalities 
(Durham & Chapman, 2014, p. 471).  
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According to MacMullen and Samson (2018), NAS is diagnosed based off maternal 
history of drug use and neonatal assessment of signs and symptoms of withdrawal. The Finnegan 
Neonatal Abstinence Scoring Tool is a five-point scale used to rate the intensity of the signs and 
symptoms with a maximum score of 44; the higher the score, the greater the severity of the 
symptoms (MacMullen & Samson, 2018). Clinical management is therefore based upon the 
severity of the symptoms. Typically, non-pharmacologic treatments are initiated first, such as 
swaddling, cluster care, limited exposure to light and sound, music therapy, cuddling, maternal-
infant bonding via breastfeeding, and rooming-in. When needed, pharmacologic interventions 
are used, with morphine being the primary medication administered, followed by methadone, 
buprenorphine, phenobarbital, and clonidine. While it may seem counterintuitive to treat the 
newborn with the same class of drug that contributed to the cause of NAS, it is the standard 
intervention for subduing the withdrawal symptoms. Yet, it seems as if more and more 
healthcare professionals are stressing the employment of alternative therapies prior to 
administering any medications, which is backed by current research. 
Significance of the Problem 
The incidence of NAS has increased over the past decade in conjunction with the opioid 
epidemic in the United States. According to the 2017 National Survey of Drug Use and Health 
organized by the US Department of Health and Human Services (HHS), 11.4 million people 
misused prescription opioids and 2.1 million people had an opioid use disorder in 2016 and 2017 
alone. In addition, there was a five-fold increase in the number of babies born with NAS from 
2000-2012, estimating to be 21,732 babies, which is equivalent to one baby born with NAS 
every 25 minutes (HHS, 2018). Babies who have been exposed to illicit drugs in utero are 
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admitted to the NICU in order to be monitored for signs and symptoms of withdrawal and treated 
as necessary.  
The length of stay in the NICU is dependent on the type of substance the baby was 
exposed to since each kind of drug elicits different responses and withdrawal periods. Because 
the length of stay in the hospital is prolonged for those babies with NAS, the cost incurred is 
significant and that trend can continue into infancy and childhood due to the effects that drugs 
can have on growth, behavior, and cognition. 
In addition, there is a likelihood that the biological mother of the child will not be able to 
assume their role as a mother due to the harm inflicted on the baby as a result of prenatal drug 
exposure. Fetal development is an extremely critical period for growth and development in a 
child’s life and opiate exposure in utero can have a negative effect on fetal growth and 
neurological development. As a result, The Department of Child Services (DCS) becomes 
involved in the case after the baby is born to evaluate whether or not the baby will be cared for 
effectively and in a safe environment in order to determine if the parents resume custody of the 
child. There is a DCS program called SENSE, or Substance Exposed Newborn Safe 
Environment, which consists of many home-visits and parent education, and it has the ultimate 
goal of keeping the families together, which is ideal for improved outcomes of the baby. 
However, if deemed unsafe, the baby will be placed into custody of a foster care family who will 
care for the child. This happens in about 25% of the cases, however, 69% of the time the infants 
are discharged to their mother, so there is hope that the family unit can be preserved (Fragassi & 
Bora, 2018). 
Overall, the effects that substance exposure in utero has is extensive, not only for the 
newborn immediately after birth, but also long-term effects, the psychological effects on the 
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mother, the cost, and the overall disruption of a family dynamic. In response to the opioid 
epidemic in the country, healthcare providers should seek out the best practice for the treatment 
of NAS so as to preserve and encourage the baby’s health and wellbeing after birth.  
Summary 
 The purpose of this thesis is to develop best practice recommendations to better provide 
care to babies who suffer from NAS after birth. The intended purpose of this research review is 
to discover what has been effective in treating NAS, as well as identify treatments that can be 
improved upon; with this information, evidence-based recommendations can be created to 
establish a first-line treatment for NAS in the NICU that has the greatest benefits for the 
newborn.  
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CHAPTER 2 
Review of Literature 
Chapter two presents a literature review focused on caring for babies with neonatal 
abstinence syndrome. The research for this thesis was conducted through searches on PubMed 
and CINAHL databases for published articles between the years of 2012 and 2019 in peer-
reviewed journals. Searches were run using the keywords “neonatal abstinence syndrome,” 
“treatment”, and “non-pharmacologic.” Ten articles were selected to be used for this review 
based on a variety of interventions analyzed and recommendations made for management of 
NAS in the hospital. The results from these articles will be applied as evidenced based 
recommendations for best practice for the care of newborns with NAS.  
Interventions for Management of Neonatal Abstinence Syndrome 
Nonpharmacologic 
 NAS, while it is an acute problem that affects the newborn, stems from a mother’s 
addiction to opioids. In that way, NAS should be treated as a “cascade of care” that encompasses 
primary prevention, prenatal care, delivery, and aftercare (Syvertsen, Toneff, Madden, & Clapp, 
2018). The opioid epidemic more commonly affects those at a social disadvantage, such as those 
who live in poverty, have a lack of education, are exposed to drug abuse across generations, and 
have limited access to opportunities (Syvertsen et al., 2018). With that being said, efforts in 
community populations should be made to target the risk factors associated with opioid use in 
order to minimize the power of unfavorable social determinants of health. In addition, 
comprehensive prenatal care should be sought, including support groups and medicated assisted 
treatment (MAT) (Syvertsen et al., 2018). At the time of delivery, a supportive health care team 
is vital for sustaining nonjudgmental care in the event of an NAS diagnosis (Syvertsen et al., 
 8 
2018). Lastly, aftercare for the families, comprised of access to drug treatment, social services, 
monitoring of child development, and ensuring a healthy home environment, can facilitate the 
transition to a stable life at home for the infant (Syvertsen et al., 2018).  
According to Sanlorenzo, Stark, and Patrick (2018), there is a decreased cost and length 
of hospital stay for infants with NAS that is associated with rooming-in by parents for treatment 
in the NICU. Parental presence at the bedside significantly reduced the duration of opioid 
therapy days and length of stay in the NICU by greater than five days (Sanlorenzo et al., 2018). 
This data suggests that rooming-in, which minimizes the separation of the maternal-infant 
relationship, can be a beneficial non-pharmacologic intervention for treatment of NAS.  
 More non-pharmacological interventions that have become more popular include: a low 
stimulation environment, continuous care provided by parents rooming in or staff if parents are 
unavailable, increased involvement of parents in care before resorting to pharmacologic 
treatments, and strictly breastfeeding provided there are no hospital policy restrictions 
(Grossman et al., 2017). The assessment of the infants in this study were based off of three 
categories: the infant’s ability to eat by breastfeeding or taking an ounce or greater from a bottle, 
to sleep undisturbed for an hour or more, and to be consoled within ten minutes, which is 
otherwise known as the eat-sleep-console method (ESC) (Grossman et al., 2017). If these criteria 
were not met, nonpharmacologic interventions would be maximized before administering a 0.05 
mg/kg dose of morphine to manage the withdrawal symptoms. After implementation of the eat, 
sleep, console protocol, there was a significant decrease in length of stay in the hospital from 22 
days to five days; decrease in number of babies treated with morphine from 54 out of 55 babies 
(98%) to six out of 44 (14%); decrease in cost of stay from $44,824 to $10,289; decrease in 
NICU admissions from all 55 babies (100%) to nine infants out of the 44 (20%); and an increase 
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in the number of infants who were breastfed (Grossman et al., 2017). It is interesting to note that 
the NICU was deemed by Grossman et al. (2017) as an unsuitable environment for managing 
NAS because the units aren’t often equipped for rooming in or sustaining non-pharmacologic 
interventions besides swaddling. This indicates that other inpatient units may be more efficient 
for managing NAS due to their low-stimulation environments and optimization of the mother-
baby dyad and family-centered care (Grossman et al., 2017).  
More recently, Grossman, Lipshaw, Osborn, and Berkwitt (2018) retrospectively 
reviewed charts of newborns managed with the ESC method that was described previously and 
results revealed that 12% of newborns received morphine using the ESC assessment tool 
whereas 62% would have received a dose if managed using the traditional Finnegan scoring tool. 
Additionally, length of stay would have been 10 days longer for those pharmacologically 
managed newborns due to the incremental process of weaning (Grossman et al., 2018). 
Wachman et al. (2018) focused on a quality improvement project to improve neonatal 
outcomes for infants with NAS. A pre-intervention group was assessed using the Finnegan 
scoring tool and were started on pharmacologic treatment when the neonates scored an eight or 
more twice or twelve or more once (Wachman et al., 2018). On the other hand, the intervention 
group was assessed using the function-based ESC model (Wachman et al., 2018). Findings 
showed that after the implementation of the ESC initiative, there was a decrease in the length of 
stay from 17 days to 11 days, decrease in pharmacologic treatment from 87.1% to 40%, and 
lastly, a decrease in adjunctive medication administration alongside pharmacologic treatments 
from 33.6% to 2.4% (Wachman et al., 2018). One limitation of the ESC implementation is that 
babies were handpicked in many of the studies to receive the intervention which is an example of 
selection bias and reduces the reliability and validity of the study.  
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 Boucher (2017) conducted a systematic review regarding rooming-in and neonatal 
outcomes as a result. In one study, she found that 79.2% of babies who had been exposed to 
opioids in utero were less likely to receive opioid treatment if they were able to room in with 
their mothers in comparison to 88.9% of the babies requiring opioid treatment who were 
cohabitating with their mothers (Boucher, 2017). In addition, those neonates who roomed-in had 
a shorter duration of pharmacologic management of NAS by five days and a shorter average 
length of stay in the hospital by seven days in comparison to those babies who did not room-in 
(Boucher, 2017). Another study the author reviewed had similar results. This particular study 
implemented an initiative for NAS management where infants who did not require 
pharmacologic management of symptoms remained in the postnatal ward (Boucher, 2017). If a 
neonate who scored three consecutive scores of eight or higher on the Finnegan Scale, 
pharmacologic treatment was indicated and that infant would be transferred to the NICU for care 
only until a maintenance dose was established as indicated by three stable Finnegan scores less 
than eight; at this point, the infant would return to the postnatal ward (Boucher, 2017). The 
outcomes measured included length of opioid therapy and average length of stay and outcomes 
from this group of infants in the new initiative were compared to the outcomes of the standard 
NICU care usually provided for infants with known opioid exposure before birth (Boucher, 
2017). Results from this study showed that 15% of infants who roomed in required opioid 
therapy, while 83% of those who did not room-in were treated pharmacologically and those that 
roomed in had an average length of stay of five days versus 29 days for those that did not room 
in (Boucher, 2017). Even among the infants that roomed in but required some pharmacologic 
treatment had an average length of stay of 24 days, which is five days less than those that didn’t 
room in at all (Boucher, 2017).  
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 Boucher’s research also looked at the alternative intervention of acupuncture and its 
outcomes for managing symptoms associated with NAS. Acupuncture is more commonly used in 
adult populations; however, it has been proven useful to treat colic and resulting agitation in 
newborns (Boucher, 2017). The National Acupuncture Detoxification Association (NADA) have 
a treatment protocol that can be implemented as an adjunctive therapy for neonates in withdrawal 
(Boucher, 2017). This protocol involves needling at five points on the ear which has been 
effective in alleviating autonomic dysfunction symptoms associated with withdrawal by 
stimulating the parasympathetic nervous system, vagus nerve, cerebral cortex, and kidneys to 
reduce inflammation, fatigue/headache, and provide an analgesic/sedative effect (Boucher, 
2017). Only three out of the five points are active reflexes in newborns, so in acupuncture 
therapy with the newborns, only those points are used (Boucher, 2017). One study conducted the 
auricular acupuncture on 76 babies and results showed that acupuncture significantly reduced the 
amount of pharmacologic treatment needed in comparison to the control group that did not 
receive acupuncture (Boucher, 2017). Another study implemented laser acupuncture, a more 
noninvasive procedure to optimize comfort, in addition to opioid management therapy after 
feedings and morphine doses (Boucher, 2017). Findings reported were that the babies feeding 
and caloric intake was improved, there was less of a need for pharmacologic intervention, length 
of stay was significantly reduced, and Finnegan scores following acupuncture therapy were 
decreased (Boucher, 2017).  
 Wu and Carre (2018) conducted a review of seven articles analyzing outcomes in 
breastfed versus formula fed neonates with exposure to opioids in utero. It is already known that 
breastfeeding improves health outcomes and can reduce a child’s risk for infections, metabolic 
diseases, and mortality (Wu & Carre, 2018). Recommendations from the American Academy of 
 12 
Pediatrics include breastfeeding exclusively for at least six months and an additional year 
alongside the incorporation of solid foods unless otherwise contraindicated (Wu & Carre, 2018). 
Breastfeeding, in fact, used to be contraindicated for mothers on opioid maintenance therapy due 
to the belief that harmful amounts of methadone were secreted in the breast milk, however, it has 
since been proven that the amount of the drug is negligible and does not exacerbate symptoms of 
NAS (Wu & Carre, 2018). Every hospital likely has their own policies regarding this matter but, 
breastfeeding is usually still encouraged if the mother is participating in a treatment program, 
receives regular prenatal care, refrains from using illicit drugs prior to 90 days before delivery, 
and proves compliant with a negative urine toxicology screening at delivery (Fragassi & Bora, 
2018). Results from the articles that met inclusion criteria are as follows: Four out of seven 
articles measured length of hospital stay as an outcome and found that breastfed infants had 
shorter hospitalizations compared to formula-fed neonates by five or more days (Wu & Carre, 
2018); Three out of the seven articles looked at severity of NAS as an outcome and found that 
the mean Finnegan score was lower in breastfed babies with an average score of 4.8 in 
comparison to the formula-fed infant’s scores of 6.5 and ultimately required less pharmacologic 
intervention (Wu & Carre, 2018); Lastly, three out of the seven articles looked at the differences 
in length of pharmacologic intervention needed between the two types of feeding and found that 
there was a shorter duration of pharmacologic treatment needed in breastfed newborns by an 
average of 20 days (Wu & Carre, 2018).  
Pharmacologic 
While most NAS management recommendations prioritizes the employment of 
nonpharmacologic interventions, it may be medically necessary to administer an opioid to 
subdue the symptoms of opioid withdrawal in the neonate. Given that this indication is a 
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possibility, Chisamore, Labana, Blitz, and Ordean (2015) looked at methods of morphine 
delivery to assess which method, symptom-only or weight-based dosing, lead to a greater 
initiation of morphine administration. Neonates in the symptom-only dosing group were more 
likely to receive more morphine, however, the babies in that group who received the morphine 
doses did so at a similar onset as the weight-based dosing group, required nearly as much of a 
dose, and had similar lengths of stay (Chisamore et al., 2015). In addition, there were only five 
out of 57 cases where the babies in the symptom-only group never reached a dose that 
represented the lowest dose (0.32 mg/kg/day) in the weight-based dosing group (Chisamore et 
al., 2015). However, the symptom-only group had higher median peak NAS scores, which may 
also contribute to a potential for an increased length of stay (Chisamore et al., 2015). 
Recommendations included utilizing a strict weaning protocol for all opioid administration to 
minimize the duration of opioid treatment and consequently, length of stay (Chisamore et al., 
2015).  
Morphine is the most commonly used medication for pharmacologic treatment of NAS. 
However, recent studies suggest that other medications may be superior in improving neonatal 
outcomes, such as decreasing days of pharmacologic treatment and average length of stay. To 
start, MacMullen and Samson (2018) highlighted advantages and disadvantages of each 
medication that can be prescribed for treatment of NAS. Morphine has no alcohol content and a 
short half-life of nine hours but causes sedation, apnea, constipation, and more frequent dosing 
(MacMullen & Samson, 2018).  Methadone has a long half-life of 26 hours and has been 
associated with shorter hospitalization times, but the treatment duration is longer, it has an 8% 
alcohol content, and frequent reassessment is necessary (MacMullen & Samson, 2018).  
Buprenorphine, which is not as commonly used, can be given sublingually and has a half-life of 
 14 
twelve hours but has a 30% alcohol content, requires more administration of adjuvant 
medications, and limited research is available on the efficacy of the drug in treating NAS 
(MacMullen & Samson, 2018).  Secondary drugs that are given include phenobarbital and 
clonidine. Phenobarbital has a long half-life of 45-100 hours and levels can be monitored but it 
has many drug-drug interactions, has a 15% alcohol content, and can cause sedation (MacMullen 
& Samson, 2018).  Clonidine on the other hand is a non-narcotic antagonist, does not cause 
sedation or have any alcohol content, and has a long half-life of 44-72 hours (MacMullen & 
Samson, 2018).  Given that it is an alpha-2 adrenergic agonist, it can cause hypotension and 
abruptly discontinuing it can lead to rebound hypertension and tachycardia (MacMullen & 
Samson, 2018).   
Disher et al. (2019) conducted a meta-analysis of randomized control trials of 
pharmacologic treatment for NAS alone or in combination with adjuvant therapies. 18 trials were 
eligible for inclusion; primary outcomes analyzed were length of treatment, and secondary 
outcomes were length of stay, need for adjuvant therapy, and adverse events (Disher et al., 
2019). Treatments that were included in the articles included  buprenorphine, clonidine, diluted 
tincture of opium and clonidine, diluted tincture of opium, morphine, methadone, and 
phenobarbital (Disher et al., 2019). Results from the study showed that sublingual buprenorphine 
was associated with a reduced length of stay; shorter than methadone, which was shorter than 
morphine (Disher et al., 2019). Hypotheses for why buprenorphine was more effective included  
a more time-effective dosing schedule improved the safety profile due to the drug’s longer half-
life and increased μ-opioid receptor activity, which can prevent more reoccurrences of 
withdrawal symptoms associated with NAS (Disher et al., 2019). However, this was the first 
 15 
article of its kind that compared the outcomes associated with different medications for treatment 
of NAS, so more research will need to be done to develop more credibility for these results.  
Conclusion 
The articles reviewed in this chapter addressed the efficacy of nonpharmacologic 
interventions for management of NAS and included exploration of pharmacologic interventions, 
knowing that it is sometimes medically indicated to administer medications. The ten articles 
varied from qualitative analyses to systematic reviews and included both small and large sample 
sizes.  The literature indicated that nonpharmacologic interventions of rooming- in, acupuncture, 
Eat-Sleep-Console method, and breastfeeding, were all effective in reducing the severity of 
withdrawal symptoms, need for pharmacologic intervention, length of hospital stay, and overall 
cost. When pharmacologic intervention becomes necessary, the literature states that a 
standardized weight-based dosing with strict weaning protocol compared to symptom-only 
scoring ensures less dosing of opioid medications, less treatment time, and shorter 
hospitalizations, which is beneficial for the infants. 
It would be also beneficial for future research to focus on long term developmental 
outcomes to see if the nonpharmacologic interventions that have been implemented have 
beneficial effects in that category. Because withdrawal produces physically debilitating effects, it 
is necessary to have the health and well-being of the child in mind, and this includes their 
neurodevelopment since that has a great effect on cognition and behavior which is manifested 
later on in life. Non-pharmacologic interventions aim to reduce the need for consumption of 
more opioids, since doing so seems counterintuitive for the sake of the baby’s health, but if they 
do not prove effective in long-term outcomes, the efficacy of the interventions will be 
undermined. In addition, pharmacologic management is not standardized, so dosing and weaning 
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protocols differ nationwide. This can be problematic seeing that more babies may receive more 
doses of opioids and are treated for longer periods of time than what may be necessary. Further 
research, not only on what medication is best, but also on minimizing doses and treatment time, 
is necessary. Based on this review of existing literature, evidence-based best practice 
recommendations are needed to assist nurses and other health care professionals to effectively 
provide care for neonates with NAS.  
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CHAPTER 3 
Best Practice Recommendations: Interventions for Management of NAS  
 The purpose of this thesis was to create informed best practice recommendations to 
manage the symptoms associated with NAS using the least invasive means. As shown in Table 1, 
this chapter details the proposed best practice recommendations to help nurses and other health 
care professionals develop a care plan that help neonates ease through withdrawal using non-
pharmacologic interventions.  
 The literature reviewed in the previous chapter detailed important findings regarding the 
efficacy of non-pharmacologic interventions and pharmacologic interventions pertaining to 
management of symptoms of NAS. As the research has shown, interventions such as rooming-in, 
breastfeeding, acupuncture, and the Eat-Sleep-Console method, were effective in reducing the 
severity of NAS symptoms and contributed to a decrease in the need for pharmacologic 
intervention, length of hospitalization in the NICU, and overall cost. In addition, the criteria in 
which medications are determined to be administered to treat NAS symptoms has been specified 
to ensure the lowest possible dose of the most effective opioids that is necessary.  
 
Table 1  
Best Practice Recommendations for Management of Neonatal Abstinence Syndrome 
Recommendation Rationale References Level of 
Evidence 
Rooming-In 
 
 Promoting the 
bonding of the 
maternal-dyad 
relationship by 
increasing parental 
 
Sanlorenzo, L. A., Stark, A. R., & Patrick, 
S. W. (2018). Neonatal abstinence 
syndrome: An update. Current 
Opinion in Pediatrics, 30(2), 185. doi: 
 
Level I 
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presence at the 
bedside reduces the 
number of opioid 
treatment days and 
length of stay. 
 
 
 
10.1097/MOP.0000000000000589 
[doi] 
 
Grossman, M.R., Berkwitt, A.K., Osborn, 
R.R., Xu, Y., Esserman, D.A., 
Shapiro, E.D., Bizzarro, M.J. (2017). 
An initiative to improve the quality of 
care of infants with neonatal 
abstinence syndrome. Pediatrics, 
139(6). doi: 10.1542/peds.2016-3360 
[doi] 
 
Boucher, A. M. (2017). Nonopioid 
management of neonatal abstinence 
syndrome. Advances in Neonatal 
Care : Official Journal of the 
National Association of Neonatal 
Nurses, 17(2), 84-90. 
doi:10.1097/ANC.0000000000000371 
[doi] 
 
 
Level III 
 
 
Level I 
Breastfeeding 
 
 The concentration of 
opiates in infants 
breastfed by mothers 
on OMT is negligible 
and that there were 
no neurological 
symptoms from the 
exposure of opiates 
through breast milk. 
 
 Breastfeeding 
strengthens the 
mother-infant dyad 
and contributes to the 
reduction of NAS 
duration and severity. 
 
 
Grossman, M.R., Berkwitt, A.K., Osborn, 
R.R., Xu, Y., Esserman, D.A., 
Shapiro, E.D., Bizzarro, M.J. (2017). 
An initiative to improve the quality of 
care of infants with neonatal 
abstinence syndrome. Pediatrics, 
139(6). doi: 10.1542/peds.2016-3360 
[doi] 
 
Wu, D., & Carre, C. (2018). The impact of 
breastfeeding on health outcomes for 
infants diagnosed with neonatal 
abstinence syndrome: A 
review. Cureus, 10(7), e3061. 
doi:10.7759/cureus.3061 [doi]  
Fragazzi, P. A. & Bora, G. (2018). 
Creating a community of support 
for children and families affected 
by opioid dependence: Identifying 
and addressing gaps in maternal-
fetal care. ZERO TO THREE 
Journal, 38 (5), 29-38.  
 
 
Level III 
 
 
Level I 
 
 
Level VII 
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Low Stimulation 
Environment 
 
 Dimming lights and 
reducing noise can 
minimize agitation of 
the newborn and 
decrease NAS scores. 
 
Grossman, M.R., Berkwitt, A.K., Osborn, 
R.R., Xu, Y., Esserman, D.A., 
Shapiro, E.D., Bizzarro, M.J. (2017). 
An initiative to improve the quality of 
care of infants with neonatal 
abstinence syndrome. Pediatrics, 
139(6). doi: 10.1542/peds.2016-3360 
[doi] 
 
 
 
Level III 
Eat-Sleep-
Console Method 
(ESC) 
 
 ESC method of 
assessing need for 
pharmacologic 
intervention 
eliminates the 
inaccuracies of the 
Finnegan scoring 
method. 
 
 If an infant can 
breastfeed effectively 
or take ≥ 1 oz from a 
bottle per feed, to 
sleep undisturbed for 
≥1 hour, and, if 
crying, to be 
consoled within 10 
minutes, then 
morphine is neither 
started nor increased 
regardless of other 
signs of withdrawal.  
 
 Treatment of NAS 
using the ESC 
method lead to 
significantly less 
frequent morphine 
treatments than if 
using Finnegan 
scoring.  
 
Grossman, M.R., Berkwitt, A.K., Osborn, 
R.R., Xu, Y., Esserman, D.A., 
Shapiro, E.D., Bizzarro, M.J. (2017). 
An initiative to improve the quality of 
care of infants with neonatal 
abstinence syndrome. Pediatrics, 
139(6). doi: 10.1542/peds.2016-3360 
[doi] 
 
Grossman, M. R., Lipshaw, M. J., Osborn, 
R. R., & Berkwitt, A. K. (2018). A 
novel approach to assessing infants 
with neonatal abstinence syndrome. 
Hospital Pediatrics, 8(1), 1-6. 
doi:10.1542/hpeds.2017-0128 [doi] 
 
Wachman, E. M., Grossman, M., Schiff, 
D. M., Philipp, B. L., Minear, S., 
Hutton, E., . . . Whalen, B. L. 
(2018). Quality improvement 
initiative to improve inpatient 
outcomes for neonatal abstinence 
syndrome. Journal of 
Perinatology: Official Journal of 
the California Perinatal 
Association, 38(8), 1114-1122. 
doi:10.1038/s41372-018-0109-8 
[doi] 
 
 
Level III 
 
 
 
Level III 
 
 
Level IV 
 
Acupuncture 
 
 Acupuncture at 3 
auricular points can 
 
Boucher, A. M. (2017). Nonopioid 
management of neonatal abstinence 
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reduce autonomic 
dysfunction 
associated with NAS. 
syndrome. Advances in Neonatal 
Care : Official Journal of the 
National Association of Neonatal 
Nurses, 17(2), 84-90. 
doi:10.1097/ANC.0000000000000371 
[doi] 
Level I 
 
Buprenorphine 
Treatment for 
Pharmacologic 
Management 
 
 Sublingual 
buprenorphine is 
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Summary of Best Practice Recommendations 
 Given that the opioid crisis is a multi-dimensional public health problem, managing NAS 
should begin at primordial prevention efforts to address social determinants of health. However, 
the literature reviewed in the previous chapter summarized significant findings regarding 
interventions to better manage NAS while in the hospital, so as to promote the best care possible 
for the infant. There are many modalities that can contribute to favorable outcomes, such as 
minimizing the need for pharmacologic interventions, shorter treatment periods, shorter length of 
stay, and lower NAS scores. Evidence showed that parents rooming-in with the infant during the 
hospital stay facilitates the maternal-newborn relationship and significantly reduces NAS scores 
and the need for administering an opioid to manage withdrawal symptoms. In addition, a low 
stimulation environment, characterized by reduced noise and low lighting can minimize the 
symptoms associated with NAS. Breastfeeding the newborn, according to facility policies, is 
recommended since the amount of opioid transferred through breast milk is negligible and can 
further bonding between the mother and infant, which has shown to reduce NAS scores and the 
need for pharmacologic management. Acupuncture at three points on the outer ear has also been 
shown to reduce the severity of the autonomic symptoms of NAS, which also contributes to 
minimizing unnecessary pharmacologic treatments since it lowers NAS scores. The most recent 
innovation in NAS management is the implementation of the Eat-Sleep-Console method to 
determine the severity in which NAS is affecting the infant in place of the Finnegan scoring tool. 
By using this more conservative scoring method, administration of opioids is reduced, and 
therefore, length of treatment and hospitalization is decreased. However, there are still cases 
where infants do show signs that deem pharmacologic treatment necessary, and the most 
effective treatments should be chosen. Sublingual buprenorphine has been shown to be the 
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optimal treatment for NAS as opposed to morphine, however if morphine is chosen, weight-
based dosing and a strict weaning protocol should be implemented.  
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CHAPTER 4 
Implementation and Evaluation 
 The initial section of this chapter will focus on implementing the creation of a sub-unit on 
a  mother-baby unit within a hospital that is aimed to serve mothers and their babies who are 
suffering from prenatal drug exposure. The staff on this wing will employ and teach about the 
evidence-based practice recommendations regarding management of NAS in order to support the 
families during their postpartum hospitalization and adjustment to caring for their baby. Based 
on the recommendations from the previous chapter, nurses, nurse educators, and lactation 
consultants will be assigned as frontline leaders who are in charge of implementing the 
interventions. In addition, they are responsible for educating the family on these interventions in 
order to allow the family to build their confidence and have an integral role in caring for their 
newborn. Before discharge, case management should ensure that the family is given resources 
regarding applicable community support groups and that continued care for the mother is pre-
arranged.  
 In order to implement this sub-unit, the Plan-Do-Study-Act (PDSA) Cycle will be used. 
The PDSA Cycle will serve as a framework for the implementation of the sub-unit into the 
Mother-Baby unit of a hospital as a quality improvement project (Institute for Healthcare 
Improvement, 2017). The PDSA cycle is a commonly used method that guides the 
implementation of evidence-based research into the clinical practice setting (Institute for 
Healthcare Improvement, 2017). The important aspects of the PDSA cycle that will be addressed 
in the implementation process of this thesis are Plan, Do, Study, and Act (Institute for Healthcare 
Improvement, 2017). 
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 In the latter section of this chapter, the evaluation of implementing the sub-unit will be 
addressed. While utilizing the PDSA cycle, testing the sub-unit will begin on a small scale, such 
as in one hospital, learning from each PDSA cycle. After refining the sub-unit through several 
PDSA cycles, the change may be implemented on a broader scale, such as among other hospitals 
within the health system that contain a maternal newborn unit. The study stage of the PDSA 
cycle will be utilized to detail the evaluation process of the sub-unit, and the act stage of the 
cycle will allow for refinements to be made based on what was learned from the previous plan, 
do, and study stages. Finally, the strengths and limitations of the sub-unit and additional 
recommendations for future research related to NAS management will be discussed. 
Implementation 
Implementing Family Centered Care on a Mother-Baby Sub-Unit 
Research has indicated that to improve the quality of care of newborns with NAS, care 
should be provided outside of the neonatal intensive care unit (NICU). Utilizing a sub-unit 
within a mother-baby floor is one approach that can be implemented to deliver evidence-based 
best practices to this particular demographic provided that the babies are medically stable.  The 
sub-unit will be theoretically implemented using the PDSA cycle on the maternity unit of a local 
hospital. Through further cycles of PDSA, the sub-unit can then be implemented among other 
hospitals within the healthcare system. 
 Plan. Plan is the first stage of the PDSA cycle that will direct the implementation of a 
NAS subunit into a hospital’s maternity unit. The planning stage begins with brainstorming ideas 
regarding multiple factors of the sub-unit such as staffing, training, and stakeholders.  
 The NAS sub-unit will have four rooms available for babies with NAS, which can also 
accommodate the mothers. According to the Association of Women's Health, Obstetric & 
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Neonatal Nursing’s (AWHONN) most recent perinatal staffing recommendations, no more than 
six women without postpartum complications, three women with complications, or two women 
recovering from caesarian section can be cared for by one nurse (AWHONN, 2011). No more 
than three newborns requiring intermediate care can be cared for by one nurse (AWHONN, 
2011). Therefore, the ideal nurse-patient ratio for this specialized couplet care unit will be one 
nurse to two couplets.  It is expected that when all the beds are occupied, two nurses will staff 
the sub-unit in addition to one patient care technician which can have more beds assigned 
beyond the subunit.  
 While the unit will be staffed with preferably experienced maternal-newborn nurses, it 
will be necessary to train them to take care of this specific population. The training will include 
teaching them about evidenced-based practice recommendations for caring for a newborn with 
NAS and their family. The nurse’s main focus is to ensure the health and wellbeing of the 
mother. They will also be responsible for facilitating the care of the newborn by educating the 
family on these best-practice care strategies to practice while in the hospital so that they family is 
confident in their ability to care for the child after discharge. While it is the goal to keep the baby 
with the mother, if at any time a nurse’s assessment indicates the need for further medical care 
than what can be provided in the unit, it is necessary to consult with the healthcare provider and 
organize a transfer to the NICU to ensure optimum health and safety of the newborn.  
Stating a clear objective for the implementation of the sub-unit is another dimension of 
the planning stage in the initial PDSA cycle (Institute for Healthcare Improvement, 2017). 
While, the nurse is responsible for primary bedside care of the newborn and mother, there are 
many other stakeholders that need to be on board with the implementation of this sub-unit. The 
nurse managers and director of the maternal-newborn unit must be the primary advocates for the 
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implementation of the care provided on the sub-unit. In the planning stage, they are responsible 
for exposing the unit staff to the aim of the evidence-based practice recommendations and ensure 
understanding of the overall purpose and objective after getting approval from the hospital 
administration (Institute for Healthcare Improvement, 2017). From there, they can coordinate 
with the neonatologists or neonatal nurse practitioners, who establish the orders for the care of 
the newborn. Because of this, those health care providers should be made aware of the 
evidenced-based practice recommendations in order for there to be a continuity of care and 
promote the best possible outcomes. In addition, they should be mindful about pharmacologic 
interventions such as what medications, if needed, have been associated with improved 
outcomes.  
The last element of the plan stage in the PDSA cycle is to develop a plan to test the 
effects of the sub-unit (Institute for Healthcare Improvement, 2017). In order to evaluate the 
effects of the PDSA cycle, the newborn’s length of stay, length of treatment, and cost of 
hospitalization will be monitored and recorded. In addition, a pre- and post- survey can be given 
to the mothers and the respective nurses in order to assess and detect changes in the confidence 
in the mother’s ability to successfully care for the newborn. Lastly, focus groups of staff can be 
held in order to obtain their feedback regarding the sub-unit so that strengths and stressors can be 
identified.  
 Do. The Do stage of the PDSA cycle indicates that the implementation should be tried 
out on a small scale (Institute for Healthcare Improvement, 2017). The theoretical 
implementation of the sub-unit will address the various evidence-based practice 
recommendations for the care of newborns with NAS. The nursing staff will be trained so that 
they learn about the recommendations in order to put them into practice. Family-centered care of 
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the newborn, which is strengthened by rooming-in, breastfeeding, and a low stimulation 
environment will be prioritized. In addition, the ESC method will be implemented for every baby 
before considering the administration of medications to aid with withdrawal symptoms. Aside 
from those recommendations, there are some techniques that can be implemented to aid in any 
gastrointestinal discomfort or general irritability. Examples of these include swaddling the baby 
with their limbs flexed, vertical rocking, shushing, swaying, side-lying, sucking, feeding, tummy 
time, and massage. Any mother and their newborn will be offered to be assigned to a room on 
the sub-unit so long as drug use is disclosed, and social services has deemed it safe to keep the 
maternal-infant dyad together. During this stage of implementation, unit staff behavior and 
reception of the sub-unit will be observed; it is also during this stage that problems and 
unexpected observations would be documented (Institute for Healthcare Improvement, 2017). 
The newborn’s length of stay, length of pharmacologic treatment, and cost of hospitalization will 
be monitored and recorded for every dyad. In addition, a pre- and post- survey can be given to 
the mothers and the nurse in order to assess and detect changes in the confidence in the mother’s 
ability to successfully care for the newborn. The last element of the Do stage would include a 
focus group held by the unit managers and director to assess staff and provider feedback 
regarding the sub-unit and its utility.  
Summary 
 The implementation process for best practice recommendations to improve the care of 
infants who have NAS was developed from research on the effectiveness of a mother-baby 
subunit for babies with NAS and the PDSA cycle for improvement. Utilizing a sub-unit that is 
geared toward supporting mothers to care for their newborn in the face of adversity ensures that 
the content associated with best-practice for the care of babies with NAS is received in an 
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effective manner to the intended audience, in this particular case, the nursing staff so that they 
are capable of teaching the mothers. Furthermore, the PDSA cycle for improvement is a model 
that takes the scientific method and applies it to a health care environment using action-oriented 
learning (Institute for Healthcare Improvement, 2017). The initial steps covered in this section 
include Plan and Do (Institute for Healthcare Improvement, 2017). In the next section, the 
PDSA’s Study and Act stages will be discussed along with the evaluation of implementing the 
sub-unit. 
Evaluation 
 The Study and Act stages of the PDSA cycle, as well as the evaluation of implementing 
the subunit, are the last portions that will be discussed with respect to the integration of the best-
practice recommendations for caring for babies with NAS into practice. The Study stage of the 
PDSA cycle allows for evaluation to determine whether or not the sub-unit was an effective 
intervention (Institute for Healthcare Improvement, 2017). The Act Stage allows for making 
necessary changes to the sub-unit based on what was learned from the previous cycle stages 
(Institute for Healthcare Improvement, 2017). 
Evaluating Family Centered Care on a Mother-Baby Sub-Unit 
 Study. During the Study stage, the unit managers and director of the mother-baby unit 
would evaluate the efficacy of implementing the sub-unit within their unit (Institute for 
Healthcare Improvement, 2017). They will be responsible for evaluating the following outcomes: 
the length of stay, the length of pharmacologic treatment, and the cost. In addition to the 
outcomes, they will evaluate the results of the pre - and post- survey to assess and detect changes 
in the confidence of the nurses to successfully support and teach these mothers about how best to 
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care for the newborn that is withdrawing and, in turn, understand how confident the mothers feel. 
Lastly, feedback obtained from the staff focus groups will be analyzed.  
 Another component of the Study stage of the PDSA cycle is to compare the collected 
data with predictions (Institute for Healthcare Improvement, 2017). The intended outcome 
associated with implementing the best practice recommendations on the sub-unit would align 
with the prediction that length of pharmacologic treatment, length of stay, and cost would all 
decrease while the nurses’ and mothers’ confidence increased (Institute for Healthcare 
Improvement, 2017). Unit staff would be expected to report that the sub-unit allowed them to 
care for both the mother and baby to the best of their abilities. The last factor of the Study stage 
is to summarize and reflect upon what was learned through the implementation of the sub-unit 
(Institute for Healthcare Improvement, 2017). 
 Act. The final stage of the PDSA cycle is the Act stage (Institute for Healthcare 
Improvement, 2017). During the Act stage, changes to the sub-unit can be made based on what 
was learned from the previous cycle stages (Institute for Healthcare Improvement, 2017). Items 
to consider may include changes to staffing, such as increasing or decreasing the nurse-patient 
ratio, or changes to the training on how to implement the best practice recommendations and 
teach the mothers. In this final stage of the PDSA cycle, a plan for the next PDSA cycle test will 
be made based on the results and refinements of this cycle (Institute for Healthcare 
Improvement, 2017). 
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Strengths and Limitations of Thesis  
 The primary strength of this best practice recommendation thesis is that it included a 
thorough review of literature that resulted in a collection of evidence-based interventions that 
will allow for better care of newborns with NAS.  This thesis incorporates a majority of the most 
current research related to the management of NAS and proposes an attempt to integrate the 
recommendations into the care of newborns in an ideal setting. By creating a sub-unit on a 
maternal-newborn floor, many of the resources provided in a hospital can be easily accessible 
such as lactation consultants, physical therapy, speech therapy, neonatologists, case 
management, and social services – all of which are necessary services that a newborn needs.  
One limitation of this thesis is that the sub-unit only caters to the mother-infant dyads that 
remain together. It is known that the Department of Child Services is involved with every case of 
prenatal drug exposure and there is a chance that their evaluations lead to separating the child 
from the biological mother. In those cases, the infant will have to be cared for elsewhere. In 
addition, if a newborn’s status were to indicate a need for more extensive medical care, the sub-
unit would not be conducive for providing that level of care.  
 
 
 
 
 
 
 
 
 31 
Summary 
The purpose of this thesis was to develop best practice recommendations to better 
provide care of newborn babies that has NAS. Current research indicates that the Finnegan 
Scoring Tool might not be the most effective modality for indicating the extent of withdrawal 
that a baby is in. It leads to a greater number of doses of morphine being administered, which 
seems counterintuitive for treating a baby who is dependent on the same class of drugs: opioids. 
Alternatively, the employment of a combination of interventions can allow for successful non-
pharmacologic management of NAS. The literature confirms the efficacy of breastfeeding, 
rooming-in, a low stimulation environment, the Eat-Sleep-Console method, and acupuncture for 
the management of symptoms associated with NAS. In an attempt to create an environment 
suitable to employ all of the recommendations for best practice, the idea of a sub-unit on a 
mother-baby unit was created. The evaluation process of the project, seen in the Study and Act 
stages of the cycle, would allow for certain outcomes to be measured such as length of stay, 
length of pharmacologic treatment, and cost. In addition, nursing staff and mothers can provide 
feedback about the education they provided and received and whether or not it had any influence 
on their perceived ability to provide the necessary support for these women and confidence to 
take care of the newborn. Overall, implementation of the sub-unit will allow nurses to care for 
and educate families on how to care for their newborn according to best practice 
recommendations in the most ideal place in an effort to produce the best possible outcomes for 
the infant and the family unit.  
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